Inhibition by iota-carrageenan of the spread of murine cytomegalovirus from the peritoneal cavity to the blood plasma

References

1. Ebihara K., Minamishima Y. 1984; Protective effect of biological response modifiers on murine cytomegalovirus infection. Journal of Virology 51:117–122
   [Google Scholar]
2. Eizuru Y., Minamishima Y., Hirano A., Kurimura T. 1978; Replication of mouse cytomegalovirus in thymidine kinase-deficient mouse cells. Microbiology and Immunology 22:755–764
   [Google Scholar]
3. Eizuru Y., Nakagawa N., Hamasuna R., Minamishima Y. 1992; Protective effect of MDP-Lys (L18), a synthetic derivative of muramyldipeptide, on murine cytomegalovirus infection. Natural Immunity 11:225–236
   [Google Scholar]
4. Gold E., Nankervis G. A. 1989; Cytomegalovirus. In Viral Infections of Humans: Epidemiology and Control pp 169–189 Evans A. S. Edited by New York & London: Plenum Press;
   [Google Scholar]
5. Griffiths P. D. 1990; Cytomegalovirus. In Principles and Practice of Clinical Virology pp 69–102 Zuckerman A. J., Banatvala J. E., Pattison J. R. Edited by Chichester: John Wiley;
   [Google Scholar]
6. Hamasuna R., Eizuru Y., Shishime Y., Minamishima Y. 1993; Protective effect of carrageenan against murine cytomegalovirus infection in mice. Antiviral Chemistry and Chemotherapy in press
   [Google Scholar]
7. Ibusuki K., Minamishima Y. 1990; Effect of Chlorella vulgaris extracts on murine cytomegalovirus infections. Natural Immunity and Cell Growth Regulation 9:121–128
   [Google Scholar]
8. Kalmar J. R., Arnold R. R., Warbington M. L., Gardner M. K. 1988; Superior leukocyte separation with a discontinuous one-step Ficoll-Hypaque gradient for the isolation of human neutrophils. Journal of Immunological Methods 110:275–281
   [Google Scholar]
9. Mims C. A., Gould J. 1978; The role of macrophages in mice infected with murine cytomegalovirus. Journal of General Virology 41:143–153
   [Google Scholar]
10. Minamishima Y., Eizuru Y., Yoshida A., Fukunishi R. 1978; Murine model for immunoprophylaxis of cytomegalovirus infection. I. Efficacy of immunization. Microbiology and Immunology 22:693–700
    [Google Scholar]
11. Ohashi T., Yoshida A., Minamishima Y. 1988; Host-mediated antiviral activity of Lactobacillus casei against cytomegalovirus infection in mice. Biotherapy 1:27–39
    [Google Scholar]
12. Ohashi T., Minamishima Y., Yokokura T., Mutai M. 1989; Induction of resistance in mice against murine cytomegalovirus by cellular components of Lactobacillus casei. Biotherapy 1:89–95
    [Google Scholar]
13. Okada M., Minamishima Y. 1987a; The efficacy of biological response modifiers against murine cytomegalovirus infection in normal and immunodeficient mice. Microbiology and Immunology 31:45–57
    [Google Scholar]
14. Okada M., Minamishima Y. 1987b; The effect of biological response modifiers on chronic and latent murine cytomegalovirus infections. Microbiology and Immunology 31:435–447
    [Google Scholar]
15. Osborn J. E. 1982; Cytomegalovirus and other herpesviruses. In The Mouse in Biomedical Research II pp 267–292 Foster J. G., Small J. D., Fox J. G. Edited by New York: Academic Press;
    [Google Scholar]
16. Whaley K., Burt A. D. 1992; Inflammation, healing and repair. In Muir’s Textbook of Pathology pp 112–165 Macsween R. N. M., Whaley K. Edited by London: Edward Arnold;
    [Google Scholar]
17. Wish L., Furth J., Storey R. H. 1950; Direct determinations of plasma, cell, and organ-blood volumes in normal and hypervolemic mice. Proceedings of the Society for Experimental Biology and Medicine 74:644–648
    [Google Scholar]